Keywords: Antianginal therapy; Antithrombotic therapy; Atherosclerosis; Chronic coronary syndromes; Clinical likelihood; Coronary artery disease; Diagnostic testing/algorithm; Guidelines; Heart team; Lipid-lowering therapy; Microvascular disease; Myocardial ischaemia; Myocardial revascularization; Outcomes; PROMS/PREMS; Shared decision-making; Stable angina; Vasospasm.